UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016486
Receipt number R000016189
Scientific Title Exploratory human PET study with 11C-(S)ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes for Alzheimer's disease
Date of disclosure of the study information 2015/02/09
Last modified on 2016/02/09 09:30:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory human PET study with 11C-(S)ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes for Alzheimer's disease

Acronym

KET-3

Scientific Title

Exploratory human PET study with 11C-(S)ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes for Alzheimer's disease

Scientific Title:Acronym

KET-3

Region

Japan


Condition

Condition

Alzheimer's disease, Mild cognitive impairment, healthy

Classification by specialty

Psychiatry Radiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Exploratory human PET study of the safety and the effectiveness of [11C](S)ketoprofen methyl ester as a potential biomarker of neuroinflammatory process for Alzheimer's disease

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Retention and uptake of [11C](S)ketoprofen methyl ester in patients with Alzheimer's disease

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

The dosage in the vein of [11C] ketoprofen methylester for PET imaging.

Interventions/Control_2

The dosage in the vein of [11C] ketoprofen methylester for PET imaging.

Interventions/Control_3

The dosage in the vein of [11C] ketoprofen methylester for PET imaging.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >

Gender

Male and Female

Key inclusion criteria

Step1
1. The subject who has intention to participate in this study, and singed informed consent.
2. Age >=20 and <45 years old, with body weight >=50kgt and <85kg, and BMI >=17.6 and <26.4.
3. The subject who was judged by clinical investigator by means of physical examination and Laboratory tests to be eligible as a participant in this study.

Step2
1. The subject who has intention to participate in this study, and singed informed consent.
2. Age >=55 years old, body weight >=50kgt and <85kg, and BMI >=17.6 and <26.4.
3. The subject who was judged by clinical investigator by means of physical examination and Laboratory tests to be eligible as a participant in this study.
4.In healthy subjects, MRI findings is age-appropriate normal or there is no change to be a clinical problem.
In patients, subjects who do not have disease that causes cognitive impairment except MCI and AD by MRI.

Key exclusion criteria

1)The subject who has a peptic ulcer.
2)The subject who has blood abnormality.
3)The subject who has dysfunction in the liver / kidney.
4)The subject who has cerebrovascular disorder.
5)The subject having cardiac failure.
6)The subject with WPW or LGL syndrome, or marked bradycardia, in electrocardiogram.
7)The subject with a history of a drug or food allergy.
8)The subject who was judged by the clinical investigator to be inappropriate as a participant in this study.

Target sample size

21


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michio Senda

Organization

Institute of Biomedical Research and Innovation

Division name

Division of Molecular Imaging

Zip code


Address

2-2, Minatojima minamimachi, chuo-ku, Kobe, Hyogo

TEL

078-304-5212

Email

senda@fbri.org


Public contact

Name of contact person

1st name
Middle name
Last name Akihito Ohnishi

Organization

Institute of Biomedical Research and Innovation

Division name

Division of Molecular Imaging

Zip code


Address

2-2, Minatojima minamimachi, chuo-ku, Kobe, Hyogo

TEL

078-304-5212

Homepage URL


Email

ohnishi@fbri.org


Sponsor or person

Institute

Institute of Biomedical Research and Innovation

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

RIKEN
Kobe University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

公益財団法人先端医療振興財団 先端医療センター (兵庫県)


Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 02 Month 07 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 30 Day

Last follow-up date

2015 Year 11 Month 30 Day

Date of closure to data entry

2015 Year 11 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 02 Month 09 Day

Last modified on

2016 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016189


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name